The National Institutes of Health notified Ossium that its proposal to demonstrate that the pool of viable, deceased donors for bone marrow transplants includes tissue donors -- deceased donors who... read more →

Leading Tissue Processor AlloSource has signed a decade-long strategic partnership with Ossium Health. The partnership combines a 10-year tissue processing relationship with a substantial financial investment. The deal is expected... read more →

Leading venture capital firm First Round Capital -- early investors in Uber, Square, Flatiron Health and more than 250 other companies -- has backed Ossium Health. The San Francisco, New... read more →

Dr. Erik Woods -- former President of the International Society for Cryobiology, Founder, President and CEO of General Biotechnology, and SVP & Lead Scientist of Cook Regentec -- joined Ossium Health... read more →